24 /100
LOW RISK
Score updated May 28, 2026

HHS — Harte Hanks, Inc. Dilution Risk Tracker

Track HHS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track HHS — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
45
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for HHS.
🔔 Track HHS — Get forecast alerts →

💹 Market Data

Market Cap$19.59M
Shares Outstanding7.42M
Float3.30M
Cash$4.53M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 2.0% shares (2025Q4 vs prior)
23 institutional holders · 2.08M shares
#1 BLAIR WILLIAM & CO/IL 660.8K shares
#2 WESTERLY CAPITAL MANAGEMENT, LLC 627.0K shares
#3 VANGUARD GROUP INC 291.6K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest45.2K
Days to Cover9.9
% of Float1.4%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news
Track HHS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking HHS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for HHS
📊 HHS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 HHS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.